Preclinical Efficacy of Experimental Peptide Therapy Suggests a New Target for Metastatic Breast Cancer Treatments, UTHealth Houston Researchers Find
April 30, 2026
April 30, 2026
HOUSTON, Texas, April 30 (TNSjou) -- The University of Texas Health Science Center at Houston issued the following news:
* * *
Preclinical efficacy of experimental peptide therapy suggests a new target for metastatic breast cancer treatments, UTHealth Houston researchers find
By Catherine Marfin
A peptide that successfully targeted and killed metastatic cancer cells in mice may open the door to developing more efficient ways to detect and treat . . .
* * *
Preclinical efficacy of experimental peptide therapy suggests a new target for metastatic breast cancer treatments, UTHealth Houston researchers find
By Catherine Marfin
A peptide that successfully targeted and killed metastatic cancer cells in mice may open the door to developing more efficient ways to detect and treat . . .